Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   19,500      
Direct Value   $6,739,296    

Indirect Value

   $118,170      
Total Shares   312,921      
Total Value   $6,857,466      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $890,329 Biocryst Pharmaceuticals Inc $397,769 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $890,329 Biocryst Pharmaceuticals Inc $397,769
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    5    

     Stock price went up :
    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-03-05 4 A $0.00 $0 D/D 12,250 260,716 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-05-15 4 A $0.00 $0 D/D 3,000 248,732 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-06-01 4 A $4.50 $4,998 D/D 1,112 26,204 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-08-31 4 A $4.15 $9,997 D/D 2,409 28,613 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-11-30 4 A $5.11 $9,995 D/D 1,956 30,569 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-02-26 4 A $10.78 $9,993 D/D 927 31,496 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-05-14 4 A $0.00 $0 D/D 3,000 189,794 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-28 4 A $15.77 $9,998 D/D 634 32,130 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-08-31 4 A $15.92 $4,999 D/D 314 32,444 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-11-30 4 A $12.06 $4,993 D/D 414 32,858 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-02-28 4 A $16.61 $5,000 D/D 301 33,159 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-05-31 4 A $9.31 $5,297 D/D 569 33,728 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 16,745 63,339 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-10-31 4 AB $6.92 $14,800 D/D 2,139 7,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2007-02-14 4 AS $20.00 $300,000 D/D (15,000) 2,829 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-10-01 4 AS $24.90 $125,471 D/D (5,000) 4,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-01-02 4 AS $35.28 $180,398 D/D (5,000) 7,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-04-01 4 AS $35.75 $29,024 D/D (805) 32,034 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-10-28 4 AS $35.00 $590,625 D/D (16,875) 46,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-07-02 4 AS $40.00 $3,813,800 D/D (95,345) 59,030 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-11-09 4 AS $18.77 $563,100 D/D (30,000) 338,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-11-10 4 AS $18.72 $561,600 D/D (30,000) 308,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-08-31 4 AS $32.00 $384,000 D/D (12,000) 245,883 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-14 4 AS $23.63 $131,735 D/D (5,550) 258,833 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-15 4 AS $24.21 $134,969 D/D (5,550) 253,283 0 -
  169  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us